Prospective drug review definition

Prospective drug review means a review of the patient's drug therapy record and prescription, as established in the rules of the Board, prior to dispensing the drug as part of a drug regimen review.
Sample 1Sample 2Sample 3
Prospective drug review means the monitoring by a pharmacist, for therapeutic appropriateness, over-utilization and under-utilization, appropriate use of generic products, therapeutic duplications, drug-disease contraindications, drug-drug interaction(s), incorrect dosage or duration of drug treatment, and clinical abuse/misuse by a pharmacist prior to the drug being dispensed.
Sample 1Sample 2Sample 3
Prospective drug review means a review of the patient's
Sample 1Sample 2

Examples of Prospective drug review in a sentence

  • Prospective drug review procedures updated to include possible review of a controlled substance prescription monitoring report or another states’ reports.

  • Prospective drug review may only be performed by a pharma- cist or an intern pharmacist working under the supervision of a Missouri licensed phar- macist.

  • The PWS should include the following sections: 1.0 Objective, 2.0 Scope, 3.0 Background and 4.0 Task/Technical Requirements.

  • Commented [WTM(40]: What is the purpose of this?(2) Prospective drug review, as defined in WAC 246-XXX-200(general provisions), must be provided as set forth in WAC 246-XXX-XXX (professional standards/counseling).

  • Any exception approved prior to 8/1/2018 must reapply to comply with the most recent University policy.

  • Prospective drug review" or "drug utilization evaluation" means a screening for potential drug therapy problems due to therapeutic duplication, drug-disease contraindications, drug-druginteractions (including serious interactions with nonprescription or over-the-counter drugs), drug-food interactions, incorrect drug dosage or duration of drug treatment, drug-allergy interactions, and clinical abuse or misuse.


More Definitions of Prospective drug review

Prospective drug review means a review of the patient's drug therapy and prescription drug order prior to dispensing the drug as part of a drug regimen review.
Sample 1

Related to Prospective drug review

  • Adverse drug reaction means any undesirable or unexpected medication related event that requires discontinuing a medication or modifying the dose, requires or prolongs hospitalization, results in disability, requires supportive treatment, is life-threatening or results in death, results in congenital anomalies, or occurs following vaccination.

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • FDA means the United States Food and Drug Administration.

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Development Plan has the meaning set forth in Section 3.2.

  • Phase IV Clinical Trial means a Clinical Trial conducted after Regulatory Approval of the applicable Product has been obtained from an appropriate Regulatory Authority as a condition to, or for the maintenance of, any Regulatory Approval, including a trial that would satisfy the requirements of 21 C.F.R. 312.85, as may be amended, or the foreign equivalent thereof.